Inovio to present at the h.c. wainwright 25th annual global investment conference

Plymouth meeting, pa. , aug. 29, 2023 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that dr. jacqueline shea, president and ceo will present at the h.c.
INO Ratings Summary
INO Quant Ranking